Pharma Mar | PHM - Loan Capital


Pharma Mar reported EUR37.75M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Almirall EUR 324.81M 61.32M Dec/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Moderna USD 610M 584M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Pharma Mar EUR 37.75M 180K Sep/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 100K 86K Sep/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025